Menu

2007

  1. 2007

    Safety and Tolerability of Concurrent Natalizumab Treatment for Patients with Crohn’s Disease Not in Remission While Receiving Infliximab

    See original study
    See summary
  2. 2007

    Certolizumab in CD

    See original study
    See summary
  3. 2007

    Certolizumab in CD

    See original study
    See summary
  4. 2007

    Probiotics in CD for postop recurrence

    See original study
    See summary
  5. 2007

    Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease

    See original study
    See summary
  6. 2007

    Mesalazine high/low dose in UC

    See original study
    See summary
  7. 2007

    Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease

    See original study
    See summary
  8. 2007

    Mesalazine high/low dose in UC

    See original study
    See summary
  9. 2007

    Adalimumab in CD

    See original study
    See summary
  10. 2007

    Adalimumab in CD

    See original study
    See summary